Steven J. Chartier

Steven J. Chartier

Director de Operaciones en BioVentrix, Inc. .

55 años
Health Technology
Consumer Services
Health Services

Perfil

Steven J.
Chartier
is currently the Chief Operating Officer at BioVentrix, Inc. and a Member at Regulatory Affairs Professionals Society.
He previously worked as the Director of Regulatory Affairs at NUCRYST Pharmaceuticals Corp.
from 2009 to 2013, Manager of Clinical Projects at Biogen, Inc., Vice President of Operations and Regulatory Affairs at Infraredx, Inc. in 2013, VP of Regulatory Affairs and Regulatory Affairs at Augmenix, Inc., Principal at Dana-Farber Cancer Institute, Inc., Coordinator of Clinical Trials at Beth Israel Deaconess Medical Center, Inc., and Chief Operating Officer at PixarBio Corp.
from 2016 to 2017.
Mr. Chartier received his undergraduate degree from St. Anselm College.

Cargos activos de Steven J. Chartier

EmpresasCargoInicio
Corporate Officer/Principal -
Director de Operaciones -
Todos los cargos activos de Steven J. Chartier

Antiguos cargos conocidos de Steven J. Chartier.

EmpresasCargoFin
ANIKA THERAPEUTICS, INC. Director Técnico/Científico/I+D 01/01/2018
PIXARBIO CORPORATION Director de Operaciones 02/02/2017
Consejero General -
Corporate Officer/Principal -
Consejero General -
Ver el detalle de la experiencia de Steven J. Chartier.

Formación de Steven J. Chartier.

St. Anselm College Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Steven J. Chartier.

Relaciones

90

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas3
BIOGEN INC.

Health Technology

PIXARBIO CORPORATION

Consumer Services

ANIKA THERAPEUTICS, INC.

Health Technology

Empresas privadas7

Health Technology

Commercial Services

Health Services

Health Technology

Health Services

Health Technology

Health Technology

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Steven J. Chartier
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA